Trial intelligence / Profile preview

Intrathecal Atropine vs IV Ondansetron for PONV in Perineal Surgery

NCT05137288Unknown

Sponsor
Sohag University
Start
Dec 2021
Primary completion
May 2022
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Randomised trial of atropine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Sohag University. Primary endpoint: frequency of attacks of postoperative nausea and vomiting. Status: unknown.

02

Drugs

atropine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT05137288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05137288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call